Location: Paris
Reports to: Global Asset Lead, Aesthetics.
A global company preparing an aesthetics launch and extending its aesthetics portfolio is building out its HA filler programme. This role takes filler assets from evaluation through development, regulatory approval and industrialisation to launch.
You act as the central integrator and technical lead across R&D, Regulatory, Medical, Quality, Manufacturing and Commercial. You own the programme end to end: assessing product design and technical characteristics, defining clinical and non-clinical evidence requirements, driving regulatory strategy across EU MDR and FDA, ensuring manufacturing and industrialisation readiness, and managing external partners through to launch. You build and own the programme plan: timelines, milestones, risks and budget. You do not set portfolio strategy; you execute on the assets selected.
Experience and profile:
Proven track record leading the development of a medical device from evaluation through registration to market launch, as the technical and programme owner across R&D, regulatory, quality and manufacturing.
Delivery experience in a regulated device environment against EU MDR and FDA pathways.
Background in HA fillers or toxins, injectable HA such as viscosupplements or biostimulators, other aesthetic devices, or Class III medical devices in any therapeutic area.
Experience managing external development, manufacturing and licensing partners.
US and FDA experience strongly preferred.
Advanced scientific or technical degree preferred.
